Cara Therapeutics | CARA - Interest Income


Cara Therapeutics reported $347K in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.06M 277K Mar/2026
Cara Therapeutics USD 347K 74K Mar/2025
Cassava Sciences USD 1.17M 47K Sep/2025
Chugai Pharma JPY 480M 465M Jun/2024
Compugen USD 1.14M 185K Dec/2025
CSL USD 18M 1000K Dec/2024
J&J USD 2.27 0.13 Jun/2026
Pacira USD 1.93M 365K Mar/2026
Pfizer USD -0.04 115M Jun/2026
RedHill Biopharma USD 7.1M 14.49M Jun/2023
Supernus Pharmaceuticals USD 2.38M 359K Mar/2026